Time spent in hormone-sensitive and castration-resistant disease states in men with advanced prostate cancer, and its health economic impact: registry-based study in Sweden

Johanna Svenssona Astellas Pharma a/s – Nordic Operations, Kastrup, DenmarkCorrespondence[email protected]
View further author information

Ingela Franck Lissbrantb Department of Oncology, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden

Oskar Gauffinc Department of Surgical Sciences, Uppsala University Hospital, Uppsala, SwedenView further author information

Marie Hjälm-Erikssond Department of Oncology and Pathology, Capio St. Göran’s Hospital, Karolinska Institute, Stockholm, SwedenView further author information

Suzanne Kilanya Astellas Pharma a/s – Nordic Operations, Kastrup, DenmarkView further author information

Karin Fagerlunda Astellas Pharma a/s – Nordic Operations, Kastrup, DenmarkView further author information

Pär Stattinc Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden

Your download is now in progress and you may close this window